SPOTLIGHT -
Dr. Hochster on Treatment Considerations for HER2+ Gastric Cancer
Howard S. Hochster, MD, FACP, discusses treatment considerations for patients with HER2-positive gastric cancer.
Read More
Dr. Hochster on Take-Home Message of the POLO Trial in Pancreatic Cancer
Howard S. Hochster, MD, FACP, discusses important takeaways from the randomized, double-blind, phase III POLO trial in pancreatic cancer.
Second-Line Treatment of R/R LBCL With Lisocabtagene Maraleucel (Liso-cel)
ZUMA-7: Axicabtagene Ciloleucel as a Second-Line Therapy for LBCL
Currently Available Treatment Options for Patients With R/R DLBCL
Overview of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
